This application relates generally to the field of medical devices. More specifically, the application relates to prosthetic valve implant devices, systems and methods for implantation within the vasculature.
Veins in the human body are weak-walled blood vessels that carry blood under low pressures back to the heart from the extremities. To help move the blood toward the heart, most frequently against the force of gravity, veins have one-way valves, which open in the direction of forward-moving blood flow and close to prevent backflow of blood. When these valves become compromised, the veins cannot function properly. Venous disease, due to incompetent venous valves, is a prevalent clinical problem. In the U.S., 20 million patients demonstrate chronic venous insufficiency, with swelling, pain, and/or ulceration of the affected extremity. An additional 74 million patients exhibit the dilation and deformity of varicose veins.
Various approaches have been advanced for addressing the clinical problem of poorly functioning venous valves. Mauch et al. (U.S. Pat. No. 7,955,346) teach a percutaneous method for creating venous valves from native vein tissue. Laufer et al. (U.S. Pat. No. 5,810,847) describes catheter placement of a clip appliance onto the cusp of a valve to restore the function of incompetent lower extremity venous valves. Multiple designs for implantable venous valves have also been described. These designs involve implantable prosthetic valves that mimic the patient's natural (autologous) valves; that is, the implants use pliable leaflet or flap valves to restore unidirectional venous flow. Examples of such implantable venous valves are described by Acosta et al. (U.S. Pat. No. 8,246,676), Shaolian et al. (U.S. Pat. No. 6,299,637), and Thompson (U.S. Pat. No. 8,377,115), for example.
In order to mimic native human peripheral venous valves, leaflet or flap valves are formed of extremely thin membrane material, to allow the valve to open properly for return flow to occur in the low pressure venous system, while still providing proper sealing and avoiding valvular insufficiency. Prosthetic membrane or flap valves are prone to failure, due to tearing from repeated opening and closing of the leaflets, permanent closure due to thrombosis and cell adhesion to the prosthetic leaflets, or leaflet inversion and incompetence over time. Currently available replacement venous valves, whether artificial or transplanted tissue valves, also often cause problems with thrombosis or clotting during long term implantation.
Therefore, it would be advantageous to have improved implantable venous valves, which would be designed to address these challenges. It would desirable, for example, to have a prosthetic venous valve that prevents and/or accommodates for the occurrence of thrombosis or cell adhesion to the valve components during long-term valve implantation. Ideally, the improved prosthetic valve would be relatively easy to implant and would address at least some of the challenges of currently available valve implants discussed above.
The embodiments described herein are directed to implantable, prosthetic vascular valve devices, systems and methods for their use. Typically, the vascular valve implants described herein are used in veins, to replace or do the work of faulty or nonexistent venous valves. However, the implants may be used in arteries or other structures in the human body, such as heart valves or other body lumens that might benefit from a prosthetic valve. Thus, the description herein of venous valve implants may also be applied to arteries and other anatomical structures.
The prosthetic venous valve assembly described in this application (sometimes referred to simply as a “venous valve” or “venous valve implant”) generally includes an anchoring portion and a mobile valve component. The anchoring component (typically referred to herein as an “anchoring frame” or “anchoring member”) in many embodiments is a self-expanding frame, although alternatively it may be expandable by other means, such as balloon expandable. The anchoring frame may be bare, partially covered or completely covered in a coating or graft material. In all of these embodiments, the anchoring frame forms a lumen from end to end. The lumen of the anchoring portion typically includes a narrowed portion (also referred to herein as the “valve seat” or “waist”) and in some cases is shaped like an hourglass.
The mobile valve component is typically referred to herein as a “ball,” although in some embodiments it may not be shaped like a ball. The ball may be spherical in shape or may have other suitable shapes, such as ovoid, football-shaped, lemon-shaped, cone-shaped or the like. The venous valve implant also includes some form of tethering or retention member (or members) for attaching the ball to the anchoring portion or otherwise preventing the ball from exiting the anchoring portion. When implanted in a vein, the mobile valve component moves away from the waist of the valve when blood flows through the valve in a forward (returning to the heart) direction, thus opening the valve and allowing forward flow of blood. The mobile valve component then drops back into contact (or at least proximity) with the narrow waist portion of the valve to close the valve and minimize or prevent backflow of blood (or “regurgitation”) through the valve. A number of different embodiments, variations and features of this implantable venous valve prosthetic device are described herein.
The mechanical nature of the prosthetic ball valve confers durability to the implant, thereby removing the modes of valve failure observed in prosthetic leaflet valves. With a ball valve, no leaflets are present that may thicken, tear or prolapse. In the prosthetic venous ball valve, the failure mode is limited to clot formation (or “thrombosis”). Therefore, it is desirable to incorporate a ball design and retention system that minimize the potential for thrombus formation within the structure of the valve assembly. Thrombus formation is dependent on the characteristics of blood flow (hemodynamics) through the valve, where flow is maintained inside the lumen formed by the implant's anchoring portion and over the mobile ball component. The orifice size of the valve seat should be maximized to avoid high fluid resistance to forward venous blood flow. Maximizing the valve seat orifice size and the ball size (which is oversized relative to the orifice to contact the valve seat), however, creates a ball with a large outer profile that is difficult to insert into position in a patient's vein. If a venous valve implant contains a self-expanding frame (or even a balloon expandable frame), the frame may reside in a compressed configuration for delivery into the vein. If a rigid ball is used in the valve assembly, its diameter becomes the limiting factor in the ability for the valve assembly to compress into a decreased delivery profile. Thus, a compressible ball is included in many embodiments described herein, to minimize the delivery system profile of the prosthetic venous valve implant. In an alternative embodiment, the ball and the orifice have similar diameters, and the ball resides fully within the orifice (thereby acting like a “plug”) when the ball is in the closed position. This configuration may allow for a smaller ball and/or a larger valve seat orifice, either or both of which may help reduce forward blood flow resistance.
Implants constructed with foreign materials can lead to clot formation in the bloodstream. The characteristics of blood flowing through the valve may also contribute to thrombus formation. When the valve opens due to forward blood flow, the ball moves out of contact with the valve seat due to forward pressure to its “open” position, as allowed by the retention constraints. The valve closes due to retrograde flow and elastic spring force (in some embodiments), creating a pressure reversal on the ball and the ball moves back into contact with the valve seat. During the excursions of the ball in and out of contact with the valve seat, the flow conditions are in a transitory state for a short duration of time. When the ball is in the open position, however, the path of blood between the ball and the inner surface of the frame should ideally be uniform (i.e., laminar flow, no stagnant areas, etc.). Maintaining a uniform flow path area between the ball and the inner surface of the frame avoids changes in blood flow velocity that lead to eddy currents and areas of static blood flow at different locations within the valve assembly. Areas of stasis in the valve contribute to clot formation or thrombosis. Additionally, venous blood flow is susceptible to thrombogenesis when wall shear rates are too low or too high. Optimally, wall shear rates of venous implants may be designed to be within a desired range, to mitigate thrombus formation. Further, if implanted devices are too restrictive with respect to forward flow back to the heart, alternative flow paths around the device in the target vessel or in nearby vessels may develop, which may lead to thrombogenesis due to reduced flow and stagnation in the implant. It is therefore believed that a prosthetic venous valve assembly should have low resistance to forward flow. This is achieved by designing the prosthetic venous valve assembly to have a low pressure drop for a given flow rate and low stiffness for embodiments with an elastic retention system. The venous valve prosthetic devices described herein include features and design characteristics that advantageously address many if not all of these issues of flows, shear, thromobogenesis and the like.
Embodiments of a venous valve implant are described in this application for improving the fluid flow within the vascular valve assembly. In most if not all embodiments, the ball of the implant (or “the valve component”) is collapsible/expandable (or “non-rigid”). It is desirable to modulate the axial position of the ball as a function of flow rate, and the embodiments herein include features to address this goal. For low flow rates, the ball may be elastically pulled to the closed position (or nearly closed) at the waist with low force, to enable valve motion (i.e., flutter). This position at low flow rates prevents the ball from resting on the frame (valve stasis) further downstream, which may cause occlusion of the implantable valve. Conversely, in order to accommodate relatively large flow rates (e.g., during exercising), the ball moves to a more open, less restrictive position to mitigate high wall shear rates that may lead to thrombus (clot) formation. Thus, embodiments described herein provided a variable position valve according to variable input flow rates, thereby helping reduce thrombus formation at both low and high flow rates.
Some embodiments also provide for a more centered ball within the valve assembly, in order to prevent the ball from resting on the frame of the assembly (valve stasis), which can cause clot formation and occlusion of the valve system. Such embodiments may incorporate a spring or elastic component or portion. In some embodiments, the spring/elastic component may work in conjunction with one or more inelastic tethers.
In one aspect of the present disclosure, a prosthetic venous valve may include: a self-expanding anchoring frame having a proximal end, a distal end, and a lumen extending through the anchoring frame from the proximal end to the distal end; a valve seat formed in or attached to the anchoring frame, the valve seat having an inner diameter; an expandable ball disposed within the lumen of the anchoring frame and having an outer diameter; and a ball retention tether attached to the expandable ball and to the anchoring frame. The expandable ball expands from a compressed configuration for delivery into the vein through a delivery catheter to an expanded configuration outside the delivery catheter, and the expandable ball in the expanded configuration moves between an open position, in which the expandable ball is located apart from the valve seat, to allow forward flow of blood through the implant, and a closed position, in which the expandable ball contacts the valve seat to reduce or prevent backflow of blood through the implant. The inner diameter of the valve seat, the outer diameter of the expandable ball, and/or a length/stiffness of the ball retention system are all configured to provide for a desired flow pattern of blood through the prosthetic venous valve.
In some embodiments, the anchoring member may be a stent that extends from a proximal end to a distal end of the implant and forms a lumen from the proximal end to the distal end. The anchoring frame may include a cylindrical proximal portion at the proximal end, a cylindrical distal portion at the distal end, an inwardly angled inlet portion between the cylindrical proximal portion and a middle of the anchoring frame, and an inwardly angled outlet portion between the cylindrical distal portion and the middle of the anchoring frame.
In some embodiments, the valve further includes a membrane disposed over at least part of the anchoring frame, where the membrane is made of polymers, hyaluronic acid, heparin and/or anticoagulant agents. In some embodiments, the anchoring frame includes multiple outward facing protrusions on the proximal end and/or the distal end. In some embodiments, the anchoring frame has an hourglass shape, and the valve seat is a narrow portion of the anchoring frame, between the proximal end and the distal end. In alternative embodiments, the anchoring frame has a bowtie shape, where the anchoring frame narrows as it extends toward a middle portion from the proximal end and the distal end and then has a larger diameter at the middle portion than at immediately adjacent regions of the anchoring frame, next to the middle portion. In some embodiments, the inner diameter of the valve seat is slightly larger than the largest outer diameter of the ball, thus allowing the ball to pass into the valve seat and act as a plug. For example, the inner diameter of the valve seat may be up to 0.5 millimeters larger than the largest outer diameter of the ball.
In various embodiments, the ball may have any of a number of suitable shapes, such as but not limited to spherical, prolate spheroid, ellipsoid, ovoid, egg shaped or asymmetrical. In one embodiment, for example, the ball has a prolate spheroid shape and includes an expandable lattice structure (or “frame”) and a membrane covering the expandable lattice. As the term “frame” is used often throughout this disclosure to describe the anchoring frame of the venous valve prosthetic device, the term “lattice” or “lattice structure” will be typically be used to describe the frame portion of a ball, when the ball has a frame/lattice and a covering or coating.
In some embodiments, the tether has a V-shape with a first end attached to the anchoring frame, a middle portion attached to the ball, and a second end attached to the anchoring frame. Alternatively, the V-shape may be formed by using two tethers, each of which is attached at one end to the anchoring frame and at an opposite end to the ball. In some embodiments, the tether is attached to eyelets on the ball and the anchoring frame. In other embodiments, the tether is attached to the covering on the ball and the anchoring frame. In some embodiments, the V-shape forms an obtuse angle, while in other embodiments, the V-shape forms an acute angle. In some embodiments, the tether is elastic or incorporates a spring element to impart elasticity. In some embodiments, the ball further includes a loop for connecting the tether to the ball.
In another aspect of the present disclosure, a method for treating a vein in a human subject first involves advancing a delivery catheter containing a prosthetic venous valve into the vein. The prosthetic venous valve may include any of the aspects and features described above. The method further involves delivering the prosthetic venous valve into the vein and removing the delivery catheter from the vein.
In some embodiments, the expandable ball is a solid, compressible foam ball. Such embodiments may optionally further include at least one weight embedded within the ball. Alternatively, the expandable ball may include an elastic shell and a filler substance inside the elastic shell. For example, the filler substance may be air, a gel or a fluid. Some embodiments include at least one weight inside the elastic shell. Optionally, the filler substance may be a curable substance that hardens when cured. In some embodiments, the filler substance is a spiral-cut, elastic, hollow sphere. In some embodiments, the expandable ball includes an aperture through which the ball retention tether is passed. In some embodiments, the expandable ball is bare with no covering. In some embodiments, the expandable ball has a density of less than 2.5 grams per square centimeter. The ball retention tether is attached to the valve seat, and the tether and the valve seat form a filling lumen, and the valve seat is accessible through a filling port to pass a filler substance through the valve seat and the tether to fill the expandable ball. In some embodiments, the expandable ball has a density of no greater than 1.06 grams per square centimeter, and the tether is elastic, to pull the ball toward the valve seat to prevent backflow of blood through the implant or to modulate the valve position in forward flow. In various embodiments, the expandable ball may be made of a material such as but not limited to thermoplastic polyurethane, elastomeric thermoplastic polyurethane, PVC, Polyethylene, polycarbonate, PEEK, ultem, PEI, polypropylene, polysulfone, FEP, PTFE, ePTFE, Nitinol, coated hollow heavy metal or combinations thereof.
In another aspect of the present disclosure, a prosthetic venous valve includes an expanding anchoring frame having an upstream end, a downstream end, a middle portion and a lumen extending through the anchoring frame from the upstream end to the downstream end. The prosthetic venous valve also includes: a valve seat including a portion of the middle portion of the anchoring frame; a ball disposed within the lumen of the anchoring frame, where the ball moves between an open position, in which the ball is located apart from the valve seat, and a closed position, in which the ball is located in contact with or near the valve seat to reduce or prevent backflow of blood through the prosthetic venous valve; and at least one ball retention tether coupled with the ball and the anchoring frame, wherein the at least one ball retention tether comprises at least one elastic component or material.
In some embodiments, the prosthetic venous valve may further include a membrane disposed over at least part of the anchoring frame. Such a membrane may be made of one or more substances, such as but not limited to polymers, hyaluronic acid, heparin and/or anticoagulant agents. In one embodiment, the anchoring frame has an asymmetric shape, and a downstream portion of the anchoring frame is longer than an upstream portion of the anchoring frame. In some embodiments, the valve seat is a tapered portion of the middle portion of the anchoring frame. In various embodiments, the anchoring frame may have a shape such as but not limited to an hourglass shape, a bowtie shape and an asymmetrical shape. In some embodiments, the inner diameter of the valve seat is larger than a largest outer diameter of the ball by 0.5 millimeters or less, thus allowing the ball to pass into the valve seat and act as a plug.
In various embodiments, the ball may have any of a number of suitable shapes, such as but not limited to spherical, prolate spheroid, ellipsoid, ovoid, egg shaped, lemon shaped and asymmetrical. In some embodiments, the ball is expandable. An expandable ball may include an expandable lattice a membrane covering the expandable lattice. In some embodiments, the membrane includes at least one aperture for allowing blood to pass into an interior of the ball.
In some embodiments, the ball retention tether has a V-shape with a first end attached to the anchoring frame, a middle portion attached to the ball, and a second end attached to the anchoring frame. In some embodiments, the ball retention tether includes a main tether member, attached at one end to the ball and at an opposite end to the anchoring frame, and the elastic component is a spring disposed over a portion of the main tether member and attached at one end to the anchoring frame. In some embodiments, the main tether member may be attached to eyelets on the ball and on the anchoring frame. In some embodiments, the main tether member is attached to a covering on the ball and to a covering on the anchoring frame. In alternative embodiments, the ball retention tether may include a first tether attached to the anchoring frame and a second tether attached to the ball, and the elastic member is a spring connecting the first tether to the second tether. In some embodiments, the ball retention tether is made of an elastic material.
In alternative embodiments, the ball retention tether may include an upstream tether attaching the ball to an upstream portion of the anchoring member and a downstream tether attaching the ball to a downstream portion of the anchoring member. Alternatively, the ball retention tether may include multiple upstream expandable fingers extending from an upstream end of the ball and multiple downstream expandable fingers extending from a downstream end of the ball. In other embodiments, the ball retention tether includes a first tether attached to the anchoring frame and a second tether attached to the ball, and the elastic member is a hinge connecting the first tether to the second tether. In some embodiments, the ball further includes a loop for connecting the ball retention tether to the ball.
In another aspect of the invention, a prosthetic venous valve includes: an expanding tubular anchoring frame extending from a first end to a second end of the venous valve prosthesis, forming a lumen; a valve seat formed by or attached to the anchoring frame; a ball in the lumen of the anchoring frame; and at least one ball retention tether attached to the ball and the anchoring frame, where the at least one ball retention tether comprises at least one elastic component or material.
In some embodiments, the elastic component is a spring disposed over a main tether member and attached to the anchoring frame. In some embodiments, the ball and the ball retention tether are configured so that the ball moves between an open position, in which the ball is located downstream of the valve seat, and a closed position, in which the ball is located closer to the valve seat or contacts the valve seat, to reduce or prevent backflow of blood. In some embodiments, the ball is expandable from a compressed configuration for delivery into the vein through a catheter to an expanded configuration outside the catheter.
These and other aspects and embodiments are described in further detail below, in reference to the attached drawing figures.
In this disclosure, the term “proximal” will be used synonymously with “upstream,” and the term “distal will be used synonymously with “downstream.” “Upstream,” in this disclosure, means farther away from the heart, in other words upstream when blood is flowing toward the heart. “Downstream,” in this disclosure, means closer to the heart, in other words downstream when blood is flowing toward the heart. Although in a vein blood sometimes flows in a retrograde direction (i.e., away from the heart, for example between heartbeats), the terms upstream and downstream in this disclosure refer to blood flow in the direction toward the heart. Similarly, “forward flow” means blood flow in a direction toward the heart, and “retrograde flow” or “backward flow” means blood flow in a direction away from the heart. “Horizontal flow” or “in a horizontal direction,” refers to blood flow in a direction straight through the blood vessel and/or the valve implant device. This definition is used regardless of the orientation in space of the blood vessel itself.
The prosthetic valve assembly described herein is commonly referred to in this disclosure as a “venous valve prosthetic device” or “simply venous valve prosthesis.” As mentioned above, any given embodiment may be used (or adapted for use) in arteries, heart valve, or other body lumens. Thus, the scope of this disclosure is not limited to use of device in veins.
A prosthetic venous valve described herein is composed of A) an expandable tubular anchoring frame extending from a first end to a second end. In some embodiments the tubular frame may form a lumen to direct blood flow. It may also define the terminal ends of the venous valve prosthesis. In some embodiments part or all of the frame may be coated or covered with materials such as anti-clotting agents (e.g. heparin) to mitigate clot formation, or polymers (e.g. ePTFE) to direct the flow of blood. In some embodiments the frame may be shaped as an hourglass or bowtie. In some embodiments the contour and area of the frame may be modified to minimize shear or turbulence within the implant. It may contain a lower-radial force section or sections that allows the implant to taper back down to nominal vessel size. It may contain one or more active anchoring mechanisms such as barbs to prevent migration. B) a valve seat formed by or attached to the anchoring frame. In some embodiments the valve seat may be formed by the frame itself or a material coupled with the frame. Alternatively the design may encourage vessel attachment and ingrowth into the device, where in some embodiments the tissue may form a part of or the entirety of the valve seat. C) a ball in the lumen of the anchoring frame. The ball may be collapsible and expandable or non-collapsible and non-expandable. It may be formed of and/or coated by various materials such as polymers, metals, anti-clotting agents (e.g. heparin). It may be formed of different shapes such as a prolate spheroid, ellipsoid, ovoid, etc. It may be hollow or filled with another substance or substances (e.g. air, blood, saline). In one embodiment, it is formed of a self-expanding metal (e.g. Nitinol) covered in a polymer (e.g. ePTFE). D) at least one retention tether coupled with the ball and the anchoring frame or vessel wall, wherein the at least one ball retention tether comprises at least one elastic component or material. In some embodiments the tether itself may be formed of an elastic material such as Neoprene, silicone, rubber elastomers, etc. In some embodiments, the tether may be couple with, or pass through, an elastic material such as a Nitinol coil. All tether and/or coupled elastic materials may be further coated in other materials (e.g. ePTFE, heparin, etc.), which may improve hemocompatibility.
Additional venous valve prosthetic devices described herein include an expandable anchoring frame (self-expandable or balloon expandable, for example), which in many embodiments is formed as a metal, lattice-type structure, similar to that of a stent.). In some embodiments, the upstream and downstream ends of the anchoring frame are wider than the middle section that forms a valve seat. A ball resides downstream of the valve seat, sometimes but not always between the downstream end of the frame and the middle section, where its retrograde movement is restricted by the valve seat and/or one or more tethers (in some embodiments). A ball retention member (e.g., tether, multiple tethers, a spring tether system, etc.) is attached to the ball and to the anchoring frame and defines the open position of the ball during forward flow. The anchoring frame may be completely bare metal or may optionally be coated or covered on one or both sides (outer surface and/or inner surface) by a polymer membrane. Any coating or covering may extend the full length of the anchoring member or may cover only part of the anchoring member, according to various embodiments. The shape of the self-expanding anchoring frame structure may be configured such that with the ball in the open position, the flow area between the surface of the ball and the inner surface of the frame remains a constant value. This constant flow path relationship between the respective surfaces of the ball and the expanding frame may be achieved by configuring the frame such that its inner cross-sectional area transitions in proportion to the radius squared, starting from the narrowed middle portion of the frame towards the largest portion of the valve in the open position. By maintaining a constant area flow path around the ball, favorable blood flow characteristics, including laminar flow and an absence of eddy currents, are provided. Reducing or eliminating eddy currents and regions of stagnant flow in the valve helps to reduce or eliminate the risk of thrombus formation. In other embodiments, the prosthetic venous valve may have an increasing area between the surface of the ball and the inner surface of the covered frame, to slow the flow velocity (or vice versa). Further, implantable valve embodiments may employ a “constant gap” design where the distance (i.e., “gap”) between the surface of the ball and the inner surface of the covered frame is constant to reduce fluid wall shear rates.
The configuration of the tether (or tethers) also factors into the ability of the prosthetic ball valve to resist thrombus formation. A single tether strand may result in an offset ball in the open valve position that rests against the side of the valve, thereby creating a stagnant area of flow that induces thrombus formation. A V-shaped tether with two frame connection points and one ball connection point may center the ball for improved long-term valve patency. A single tether strand incorporating elasticity may preferably modulate the position of the valve based on flow rate thereby preventing stasis at lower flow rates and reducing high shear conditions at higher flow rates.
A prosthetic valve implant may be configured to present a minimal delivery profile by consisting of a super-elastic metal lattice structure frame with a ball valve centered within the frame, and such ball valve comprised of a self-expanding super-elastic lattice shaped as a spherical or prolate spheroid form, or one of many other possible shapes, which is then covered (or otherwise encapsulated) with a polymer membrane. The polymer used to cover the ball may be comprised of expanded polytetrafluoroethylene (ePTFE), polytetrafluoroethylene (PTFE), polyurethane, or a suitable combination such as polyurethane inside the valve lattice and PTFE outside the valve lattice heat bonded to encapsulate the valve lattice and form a membrane that directs blood flow through the lumen and around the ball in vivo. The frame may be fully covered (abluminally, adluminally or fully encapsulated), partly covered by length (also by the aforementioned embodiments), or left bare. In embodiments where the anchoring frame is bare metal (or partially bare metal), the native vein or other blood vessel in which the device is implanted will tend to grow into or through the openings in the lattice of the anchoring frame. In some embodiments, the native tissue may form the valve seat of the device after implantation (or part of the valve seat). The native vein then acts as part of the as the anchoring frame's luminal flow surface (or “inner surface” or “inner wall”). In fact, in some embodiments the anchoring frame is designed to encourage vessel wall ingrowth to used the vessel wall tissue as part of the device itself. The ball may be positioned within the self-expanding frame by a polymer tether attached to the ball and a location (or plurality of locations) on the frame. The polymer tether may be a monofilament formed of ePTFE, PTFE, Nylon, polypropylene, or other material. The tether may also be formed of multiple strands that attach to one or more points on the frame, and one or more points on the covered super-elastic ball. Further, the tether may be elastic or may pass through (or otherwise be affixed to) a spring element to impart elasticity and form a spring-tether system for ball retention.
The self-expanding ball and the self-expanding frame are preferably configured to optimize the characteristics of blood flow through the valve implant. Blood flow through a tubular structure such as the venous valve is governed by the Hagen-Poiseuille Law for laminar fluid flow that states that axial fluid flow velocity assumes a parabolic shape, with the flow velocity equal to zero at the inner wall of the tube and increasing in proportion to the radius squared. The velocity of incompressible blood flowing between the ball and the frame varies linearly according to the cross-sectional area of the flow path, following the formula A1v1=A2v2, where A1 is the cross-sectional area of a tube at point 1, v1 is the fluid flow velocity at point 1, A2 is the cross-sectional area of the tube at point 2, and v2 is the fluid flow velocity at point 2. If the cross-sectional area of fluid flow path decreases, the fluid flow velocity increases accordingly in a linear fashion. Therefore, by maintaining a constant cross-sectional fluid flow path between the ball and the frame wall, blood flow velocity remains uniform. Blood flow velocity changes may create eddy currents, areas of stasis (or reduced flow), or regions of high wall shear rates that may initiate clot formation leading to valve failure. In some embodiments, the venous valve prosthesis described herein includes a constant cross-sectional fluid flow path.
Similarly, the position of the ball during opening and closing of the valve is related to the propensity for post-implant clot formation. If the ball is not centered within the valve, thrombus may preferentially form in a low flow contact region between the ball and the frame. A ball retention system is proposed that utilizes a V-shaped monofilament to attach the ball to the frame. A longer distance between the ball and the frame attachment sites has been demonstrated on bench flow model studies to be superior to a shorter tether distance for higher flow rates. A shorter distance between the ball and the frame attachment sites has been demonstrated on bench flow model studies to be superior to a longer tether distance for lower flow rates. If the included angle defined by two segments of a V-shaped tether is an acute angle (less than 90 degrees), lower flow shear is induced by the tether segments versus a V-shaped tether with an obtuse (greater than 90 degrees) included angle. Thus, in some embodiments, the venous valve prosthesis described herein includes a V-shaped tether with an acute angle relative to the wall of the anchoring member.
Another aspect of tether and ball interaction that discourages thrombus formation on the ball during antegrade venous flow is the provision of a tether that promotes dynamic movement of the ball in the open position. If a ball centered in the flow path exhibits small axial and lateral movement or flutter when the valve is open, this motion may prevent thrombus from forming on the surface of the ball. This motion is enabled by providing that a V-shaped tether is comprised of a material with suitably low bending stiffness. In addition, a linkage may be formed at the site of V-tether attachment to the ball, with the attachment of a small loop of either suture material or metal such as stainless steel to the ball, with secondary attachment of the V-tether to the loop on the ball. Similarly, the segments of the V-tether may attach to the eyelets, loops formed in the superelastic frame or directly to the membrane. These eyelets allow maximal tether limb mobility to enhance ball movement or flutter in the valve open position.
Referring now to
Referring now to
Provision of a small degree of ball motion when the valve is in the open position may prevent thrombus formation on the ball.
Referring now to
Referring now to
Referring now to
In the embodiment of
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
Referring now to
The foregoing is believed to be a complete and accurate description of the invention. In alternative embodiments, however, any of the described features may combined in different ways or altered, without departing from the scope of the invention.
This application claims the benefit of U.S. Provisional Patent Application No. 63/033,312, filed Jun. 2, 2020, entitled, “VENOUS VALVE WITH ENHANCED FLOW PROPERTIES.” The disclosure of this priority application is hereby incorporated by reference in its entirety into the present application.
Number | Date | Country | |
---|---|---|---|
63033312 | Jun 2020 | US |